Manufacturing Roundup: Terumo BCT partners with BioBridge subsidiary to manufacture cell and gene therapies; WuZi opens plant for HPAPI production

As the manufacturing of cell and gene therapies is ramping up and companies are starting to invest in their manufacturing capabilities, Terumo Blood and Cell Technologies has formed a partnership to stay in the game.

According to the company, it has signed a new collaborative agreement with GenCure, a subsidiary...

Click to view original post